Patients with AD | Control subjects (n=8) | ||||
---|---|---|---|---|---|
2 ε4 (n=8) | 1 ε4 (n=13) | 0 ε4 (n=10) | all AD (n=31) | ||
Right frontal cortex: | |||||
Baseline | 0.87 (0.07) | 0.89 (0.09) | 0.84 (0.10) | 0.87 (0.09) | 0.87 (0.07) |
Follow up | 0.81 (0.11) | 0.85 (0.10) | 0.76 (0.15) | 0.81 (0.12) | 0.89 (0.05) |
Left frontal cortex: | |||||
Baseline | 0.83 (0.09) | 0.85 (0.10) | 0.80 (0.12) | 0.83 (0.10) | 0.85 (0.03) |
Follow up | 0.79 (0.10) | 0.81 (0.10) | 0.72 (0.17) | 0.78 (0.13) | 0.85 (0.07) |
Right temporal cortex: | |||||
Baseline | 0.85 (0.04)2-150 | 0.84 (0.05)2-150 | 0.86 (0.04)2-150 | 0.85 (0.04)2-150 | 0.90 (0.04) |
Follow up | 0.78 (0.06) | 0.81 (0.08) | 0.84 (0.10) | 0.81 (0.06)2-150 | 0.88 (0.06) |
Left temporal cortex: | |||||
Baseline | 0.80 (0.08) | 0.82 (0.07) | 0.80 (0.12) | 0.81 (0.09)2-150 | 0.88 (0.05) |
Follow up | 0.73 (0.09) | 0.77 (0.11) | 0.77 (0.14) | 0.76 (0.11)2-150 | 0.85 (0.04) |
Right parietal cortex: | |||||
Baseline | 0.80 (0.06) | 0.84 (0.07) | 0.84 (0.04) | 0.83 (0.06)2-150 | 0.88 (0.04) |
Follow up | 0.76 (0.05)2-150 | 0.79 (0.08)2-150 | 0.79 (0.10)2-150 | 0.78 (0.05)2-150 | 0.88 (0.05) |
Left parietal cortex: | |||||
Baseline | 0.75 (0.08) | 0.80 (0.08) | 0.81 (0.10) | 0.79 (0.09)2-150 | 0.86 (0.04) |
Follow up | 0.72 (0.07)2-150 | 0.73 (0.10)2-150 | 0.75 (0.13)2-150 | 0.73 (0.10)2-150 | 0.87 (0.04) |
Right occipital cortex: | |||||
Baseline | 0.91 (0.08) | 0.93 (0.07) | 0.95 (0.06) | 0.93 (0.07) | 0.92 (0.04) |
Follow up | 0.84 (0.10)† 2-150 | 0.89 (0.06) | 0.95 (0.06) | 0.90 (0.08) | 0.94 (0.05) |
Left occipital cortex: | |||||
Baseline | 0.88 (0.09) | 0.90 (0.08) | 0.96 (0.07) | 0.92 (0.08) | 0.91 (0.07) |
Follow up | 0.82 (0.07)† 2-150 | 0.86 (0.10)† | 0.94 (0.07) | 0.87 (0.10) | 0.92 (0.05) |
↵2-150 p<0.05 v controls, † v 0 ε4 subgroup, ANOVA.
Values are expressed as mean (SD).